These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 14770365)

  • 1. [Osteopetrosis, from mouse to man].
    Blin-Wakkach C; Bernard F; Carle GF
    Med Sci (Paris); 2004 Jan; 20(1):61-7. PubMed ID: 14770365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and characterization of new osteoclast progenitor cell lines derived from osteopetrotic and wild type mice.
    Blin-Wakkach C; Breuil V; Quincey D; Bagnis C; Carle GF
    Bone; 2006 Jul; 39(1):53-60. PubMed ID: 16503212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis.
    Frattini A; Pangrazio A; Susani L; Sobacchi C; Mirolo M; Abinun M; Andolina M; Flanagan A; Horwitz EM; Mihci E; Notarangelo LD; Ramenghi U; Teti A; Van Hove J; Vujic D; Young T; Albertini A; Orchard PJ; Vezzoni P; Villa A
    J Bone Miner Res; 2003 Oct; 18(10):1740-7. PubMed ID: 14584882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the nonresorptive phenotype of osteoclast-like cells from patients with malignant osteopetrosis: a new approach to investigating pathogenesis.
    Flanagan AM; Sarma U; Steward CG; Vellodi A; Horton MA
    J Bone Miner Res; 2000 Feb; 15(2):352-60. PubMed ID: 10703938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematological defects in the oc/oc mouse, a model of infantile malignant osteopetrosis.
    Blin-Wakkach C; Wakkach A; Sexton PM; Rochet N; Carle GF
    Leukemia; 2004 Sep; 18(9):1505-11. PubMed ID: 15284856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoclast biology: lessons from mammalian mutations.
    Marks SC
    Am J Med Genet; 1989 Sep; 34(1):43-54. PubMed ID: 2683780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of osteoclast-rich and osteoclast-poor osteopetrosis in adult mice sheds light on the role of the osteoclast in coupling bone resorption and bone formation.
    Thudium CS; Moscatelli I; Flores C; Thomsen JS; Brüel A; Gudmann NS; Hauge EM; Karsdal MA; Richter J; Henriksen K
    Calcif Tissue Int; 2014 Jul; 95(1):83-93. PubMed ID: 24838599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are nonresorbing osteoclasts sources of bone anabolic activity?
    Karsdal MA; Martin TJ; Bollerslev J; Christiansen C; Henriksen K
    J Bone Miner Res; 2007 Apr; 22(4):487-94. PubMed ID: 17227224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose busulphan conditioning and neonatal stem cell transplantation preserves vision and restores hematopoiesis in severe murine osteopetrosis.
    Askmyr M; Holmberg J; Flores C; Ehinger M; Hjalt T; Richter J
    Exp Hematol; 2009 Feb; 37(2):302-8. PubMed ID: 19100677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human osteopetrosis and other sclerosing disorders: recent genetic developments.
    de Vernejoul MC; Bénichou O
    Calcif Tissue Int; 2001 Jul; 69(1):1-6. PubMed ID: 11685426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lentiviral gene transfer of TCIRG1 into peripheral blood CD34(+) cells restores osteoclast function in infantile malignant osteopetrosis.
    Moscatelli I; Thudium CS; Flores C; Schulz A; Askmyr M; Gudmann NS; Andersen NM; Porras O; Karsdal MA; Villa A; Fasth A; Henriksen K; Richter J
    Bone; 2013 Nov; 57(1):1-9. PubMed ID: 23907031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic Stem Cell-Targeted Neonatal Gene Therapy with a Clinically Applicable Lentiviral Vector Corrects Osteopetrosis in
    Löfvall H; Rothe M; Schambach A; Henriksen K; Richter J; Moscatelli I
    Hum Gene Ther; 2019 Nov; 30(11):1395-1404. PubMed ID: 31179768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grey-lethal mutation induces severe malignant autosomal recessive osteopetrosis in mouse and human.
    Chalhoub N; Benachenhou N; Rajapurohitam V; Pata M; Ferron M; Frattini A; Villa A; Vacher J
    Nat Med; 2003 Apr; 9(4):399-406. PubMed ID: 12627228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal hematopoietic stem cell transplantation cures oc/oc mice from osteopetrosis.
    Johansson M; Jansson L; Ehinger M; Fasth A; Karlsson S; Richter J
    Exp Hematol; 2006 Feb; 34(2):242-9. PubMed ID: 16459192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteopetrosis--multiple pathways for the interception of osteoclast function.
    Marks SC
    Appl Pathol; 1987; 5(3):172-83. PubMed ID: 3304355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Msx2 -/- transgenic mice develop compound amelogenesis imperfecta, dentinogenesis imperfecta and periodental osteopetrosis.
    Aïoub M; Lézot F; Molla M; Castaneda B; Robert B; Goubin G; Néfussi JR; Berdal A
    Bone; 2007 Nov; 41(5):851-9. PubMed ID: 17878071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards a better understanding and new therapeutics of osteopetrosis.
    Askmyr MK; Fasth A; Richter J
    Br J Haematol; 2008 Mar; 140(6):597-609. PubMed ID: 18241253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An alternative splicing variant in Clcn7-/- mice prevents osteopetrosis but not neural and retinal degeneration.
    Rajan I; Read R; Small DL; Perrard J; Vogel P
    Vet Pathol; 2011 May; 48(3):663-75. PubMed ID: 20448277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe developmental bone phenotype in ClC-7 deficient mice.
    Neutzsky-Wulff AV; Sims NA; Supanchart C; Kornak U; Felsenberg D; Poulton IJ; Martin TJ; Karsdal MA; Henriksen K
    Dev Biol; 2010 Aug; 344(2):1001-10. PubMed ID: 20599900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoclast biology in the osteopetrotic (op) rat.
    Marks SC; Popoff SN
    Am J Anat; 1989 Dec; 186(4):325-34. PubMed ID: 2589217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.